Stay updated on Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-01T15:18:33.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and directs visitors to transition updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-25T14:28:55.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T14:46:40.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:45:07.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    New revision v3.7.0 appears in the record history, replacing the older v3.6.6. This reflects an update to the page version rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-20T15:46:46.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a new version of the page rather than any substantive content changes.
    Difference
    0.1%
    Check dated 2026-08-29T23:57:47.000Z thumbnail image

Stay in the know with updates to Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Olaparib in Advanced Bladder Cancer Clinical Trial page.